KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Goodwill: 2010-2022

Historic Goodwill for Nektar Therapeutics (NKTR) over the last 13 years, with Dec 2022 value amounting to $76.5 million.

  • Nektar Therapeutics' Goodwill changed negligibly% to $76.5 million in Q4 2022 from the same period last year, while for Dec 2022 it was $76.5 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $76.5 million for FY2022, which is negligibly% changed negligibly from last year.
  • As of FY2022, Nektar Therapeutics' Goodwill stood at $76.5 million, which was down 0.00% from $76.5 million recorded in FY2021.
  • Nektar Therapeutics' Goodwill's 5-year high stood at $76.5 million during FY2018, with a 5-year trough of $76.5 million in FY2018.
  • For the 3-year period, Nektar Therapeutics' Goodwill averaged around $76.5 million, with its median value being $76.5 million (2022).